Tradestie Institutional Equity Comparison Engine

RSPH vs RSPT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

RSPH Overall Edge

RSPH Captures Institutional Edge (2โ€“0 Pillars ยท 3โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Invesco S&P 500 Equal Weight Health Care ETF (RSPH) driven by superior Momentum & Technical, Options & Structure. Fundamentally, RSPH trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus RSPT at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, RSPH sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against RSPT sits in UNCLASSIFIED (7th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
RSPH N/M vs RSPT N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner RSPH
1Y +25.7% vs +23.5% ยท 52W Pos 74% vs 43%
Options & Structure Winner RSPH
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (7th %ile IV)
RSPH NYSE Arca
Invesco S&P 500 Equal Weight Health Care ETF
Institutional Equity
$38.75
-0.95% 1D
Market Cap N/A
1M Return -2.54%
1Y Return +25.69%
Forward P/E N/M
Unified AI Score
45.1 / 100 HOLD
Tech 42.0 Fund 40.0 Flow 50.0 Mom 20.9
RSPT NYSE Arca
Invesco S&P 500 Equal Weight Technology ETF
Institutional Equity
$53.47
-5.96% 1D
Market Cap N/A
1M Return -16.39%
1Y Return +23.54%
Forward P/E N/M
Unified AI Score
41.7 / 100 SELL
Tech 25.0 Fund 54.0 Flow 50.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RSPH +25.69% RSPT +23.54% Spread: +2.15 pp (RSPH Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
RSPH TTM Op. Margin: N/A RSPT TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RSPH vs RSPT. Trailing 12-month operating profitability (RSPH N/A vs RSPT N/A) and valuation multiples (RSPH N/M vs RSPT N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RSPH (3) vs RSPT (0)
Institutional Metric RSPH RSPT Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 74% ($30โ€“$42) 43% ($41โ€“$69) Stronger Trend RSPH
Beta / 30D Volatility Risk Regime 0.44ฮฒ ยท 21% Vol 1.66ฮฒ ยท 41% Vol Lower Realized Risk RSPH
Unified Institutional Score Composite Signal 45.1 / 100 (HOLD) 41.7 / 100 (SELL) Higher Composite RSPH

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RSPH vs RSPT Buy Guide
RSPH UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live RSPH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
RSPT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 7th %ile
IV Regime Compressed (<25th %ile)
Live RSPT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RSPH nor RSPT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.